Gene · 9436
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of LncRNAs in tumor immunotherapy. | Cancer Cell Int | 2023 | 36810034 | PubTator, text mining | PubMed |
| γδ T cells and their clinical application in colon cancer. | Front Immunol | 2023 | 36793708 | PubTator, text mining | PubMed |
| Butyrate limits human natural killer cell effector function. | Sci Rep | 2023 | 36792800 | PubTator, text mining | PubMed |
| Advances in NK cell therapy for brain tumors. | NPJ Precis Oncol | 2023 | 36792722 | PubTator, text mining | PubMed |
| Microgravity and immune cells. | J R Soc Interface | 2023 | 36789512 | PubTator, text mining | PubMed |
| Innate lymphoid cell (ILC) subsets are enriched in the skin of patients with hidradenitis suppurativa. | PLoS One | 2023 | 36780439 | PubTator, text mining | PubMed |
| Natural Killer T-like Cells: Immunobiology and Role in Disease. | Int J Mol Sci | 2023 | 36769064 | PubTator, text mining | PubMed |
| The Potential of Dendritic-Cell-Based Vaccines to Modulate Type 3 Innate Lymphoid Cell Populations. | Int J Mol Sci | 2023 | 36768726 | PubTator, text mining | PubMed |
| Natural Killer Cell-Based Immunotherapy against Glioblastoma. | Int J Mol Sci | 2023 | 36768432 | PubTator, text mining | PubMed |
| Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infection. | Cells | 2023 | 36766795 | PubTator, text mining | PubMed |
| People with Primary Progressive Multiple Sclerosis Have a Lower Number of Central Memory T Cells and HLA-DR+ Tregs. | Cells | 2023 | 36766781 | PubTator, text mining | PubMed |
| Helper Innate Lymphoid Cells-Unappreciated Players in Melanoma Therapy. | Cancers (Basel) | 2023 | 36765891 | PubTator, text mining | PubMed |
| Chemotherapeutics Used for High-Risk Neuroblastoma Therapy Improve the Efficacy of Anti-GD2 Antibody Dinutuximab Beta in Preclinical Spheroid Models. | Cancers (Basel) | 2023 | 36765861 | PubTator, text mining | PubMed |
| A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors. | Cell Death Dis | 2023 | 36765035 | PubTator, text mining | PubMed |
| Newly identified form of phenotypic plasticity of cancer: immunogenic mimicry. | Cancer Metastasis Rev | 2023 | 36754910 | PubTator, text mining | PubMed |
| Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T. | Mol Cancer | 2023 | 36750830 | PubTator, text mining | PubMed |
| The biology of TREM receptors. | Nat Rev Immunol | 2023 | 36750615 | PubTator, text mining | PubMed |
| NK cell education: Physiological and pathological influences. | Front Immunol | 2023 | 36742337 | PubTator, text mining | PubMed |
| Significance of logistic regression scoring model based on natural killer cell-mediated cytotoxic pathway in the diagnosis of colon cancer. | Front Immunol | 2023 | 36742322 | PubTator, text mining | PubMed |
| HIV vaccine candidate efficacy in female macaques mediated by cAMP-dependent efferocytosis and V2-specific ADCC. | Nat Commun | 2023 | 36732510 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9436/papers?page=20